OraSure Over-The-Counter HIV Test: Complete PMA Filing Planned By Year End
This article was originally published in The Pink Sheet Daily
Executive Summary
The application will be submitted in three parts to give FDA more time to absorb the vast trove of information and potentially speed up the process, CEO Michels said.
You may also be interested in...
Chembio Joins The Race For Over-The-Counter HIV Test
Chembio Diagnostics intends to join the growing field of companies pursuing over-the-counter indications for their HIV tests now that its products have received FDA approval
FDA Panel Mulls Clinical Studies, Labeling For Over-The-Counter HIV Tests
Over-the-counter (OTC) HIV test kits would answer an unmet need, but clinical trials and product labeling must be carefully crafted to ensure that benefits outweigh the risks, according to FDA's Blood Products Advisory Committee
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.